Biontech and cepi expand partnership to strengthen africa's mrna vaccine ecosystem

Mainz, germany/oslo, norway, may 29, 2024 – biontech se (nasdaq: bntx, “biontech”, “the company”) and the coalition for epidemic preparedness innovations (“cepi”) are expanding their strategic partnership to contribute to building a sustainable and resilient end-to-end african vaccine ecosystem. cepi is committing up to us $145 million1 to support biontech to establish mrna vaccine r&d, clinical and commercial-scale manufacturing capabilities at the company's facility in kigali, rwanda. these capabilities will contribute to efforts to better prepare for potential future epidemic and pandemic threats in africa.
BNTX Ratings Summary
BNTX Quant Ranking